RHHBF
Price
$363.10
Change
+$14.00 (+4.01%)
Updated
Sep 4 closing price
Capitalization
273.16B
SNPHY
Price
$10.90
Change
-$0.08 (-0.73%)
Updated
Sep 5 closing price
Capitalization
3.62B
Interact to see
Advertisement

RHHBF vs SNPHY

Header iconRHHBF vs SNPHY Comparison
Open Charts RHHBF vs SNPHYBanner chart's image
Roche Holding
Price$363.10
Change+$14.00 (+4.01%)
Volume$318
Capitalization273.16B
Santen Pharmaceutical
Price$10.90
Change-$0.08 (-0.73%)
Volume$757
Capitalization3.62B
RHHBF vs SNPHY Comparison Chart in %
Loading...
RHHBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHBF vs. SNPHY commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHBF is a Hold and SNPHY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (RHHBF: $363.10 vs. SNPHY: $10.90)
Brand notoriety: RHHBF and SNPHY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHBF: 498% vs. SNPHY: 22%
Market capitalization -- RHHBF: $273.16B vs. SNPHY: $3.62B
RHHBF [@Pharmaceuticals: Major] is valued at $273.16B. SNPHY’s [@Pharmaceuticals: Major] market capitalization is $3.62B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $651.91B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $89.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHBF’s FA Score shows that 1 FA rating(s) are green whileSNPHY’s FA Score has 0 green FA rating(s).

  • RHHBF’s FA Score: 1 green, 4 red.
  • SNPHY’s FA Score: 0 green, 5 red.
According to our system of comparison, RHHBF is a better buy in the long-term than SNPHY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHBF’s TA Score shows that 5 TA indicator(s) are bullish while SNPHY’s TA Score has 4 bullish TA indicator(s).

  • RHHBF’s TA Score: 5 bullish, 5 bearish.
  • SNPHY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SNPHY is a better buy in the short-term than RHHBF.

Price Growth

RHHBF (@Pharmaceuticals: Major) experienced а +9.73% price change this week, while SNPHY (@Pharmaceuticals: Major) price change was +2.93% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.16%. For the same industry, the average monthly price growth was +3.94%, and the average quarterly price growth was +10.41%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.16% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBF($273B) has a higher market cap than SNPHY($3.62B). RHHBF has higher P/E ratio than SNPHY: RHHBF (24.87) vs SNPHY (15.56). RHHBF YTD gains are higher at: 20.558 vs. SNPHY (7.708). SNPHY has higher annual earnings (EBITDA): 51.1B vs. RHHBF (18B). SNPHY has more cash in the bank: 85.9B vs. RHHBF (12B). SNPHY has higher revenues than RHHBF: SNPHY (303B) vs RHHBF (63.5B).
RHHBFSNPHYRHHBF / SNPHY
Capitalization273B3.62B7,546%
EBITDA18B51.1B35%
Gain YTD20.5587.708267%
P/E Ratio24.8715.56160%
Revenue63.5B303B21%
Total Cash12B85.9B14%
Total Debt33BN/A-
FUNDAMENTALS RATINGS
RHHBF vs SNPHY: Fundamental Ratings
RHHBF
SNPHY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5059
P/E GROWTH RATING
1..100
3690
SEASONALITY SCORE
1..100
8565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBF's Valuation (14) in the null industry is in the same range as SNPHY (34). This means that RHHBF’s stock grew similarly to SNPHY’s over the last 12 months.

RHHBF's Profit vs Risk Rating (95) in the null industry is in the same range as SNPHY (100). This means that RHHBF’s stock grew similarly to SNPHY’s over the last 12 months.

RHHBF's SMR Rating (99) in the null industry is in the same range as SNPHY (100). This means that RHHBF’s stock grew similarly to SNPHY’s over the last 12 months.

RHHBF's Price Growth Rating (50) in the null industry is in the same range as SNPHY (59). This means that RHHBF’s stock grew similarly to SNPHY’s over the last 12 months.

RHHBF's P/E Growth Rating (36) in the null industry is somewhat better than the same rating for SNPHY (90). This means that RHHBF’s stock grew somewhat faster than SNPHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHBFSNPHY
RSI
ODDS (%)
Bearish Trend 3 days ago
69%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
66%
Momentum
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
59%
MACD
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
64%
Bearish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 4 days ago
55%
Declines
ODDS (%)
Bearish Trend 26 days ago
56%
Bearish Trend 12 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
68%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
Bearish Trend 6 days ago
59%
Bearish Trend 3 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
RHHBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STXS2.900.14
+5.07%
Stereotaxis
JAMF9.180.19
+2.11%
Jamf Holding Corp
CACC522.611.88
+0.36%
Credit Acceptance Corp
ENB48.260.10
+0.21%
Enbridge
FATBB2.60N/A
N/A
FAT Brands

RHHBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBF has been loosely correlated with RHHBY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBF
1D Price
Change %
RHHBF100%
N/A
RHHBY - RHHBF
36%
Loosely correlated
+0.61%
RHHVF - RHHBF
29%
Poorly correlated
+0.70%
OTSKY - RHHBF
10%
Poorly correlated
+2.67%
PTKFY - RHHBF
6%
Poorly correlated
N/A
SNPHY - RHHBF
6%
Poorly correlated
-0.77%
More

SNPHY and

Correlation & Price change

A.I.dvisor tells us that SNPHY and SNPHF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHY and SNPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHY
1D Price
Change %
SNPHY100%
-0.77%
SNPHF - SNPHY
7%
Poorly correlated
N/A
RHHVF - SNPHY
7%
Poorly correlated
+0.70%
RHHBF - SNPHY
6%
Poorly correlated
N/A
RHHBY - SNPHY
5%
Poorly correlated
+0.61%
OTSKY - SNPHY
4%
Poorly correlated
+2.67%
More